Gregor Heitzinger
Overview
Explore the profile of Gregor Heitzinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halavina K, Koschatko S, Jantsch C, Autherith M, Petric F, Rockel A, et al.
JACC Adv
. 2025 Jan;
4(2):101544.
PMID: 39886314
Background: Degenerative severe aortic stenosis (AS) is treated by valve replacement to improve outcome. Despite diagnostic advancements, many AS patients are still diagnosed late with advanced heart failure. Objectives: The...
2.
Comparative Assessment of CMR-Determined Extracellular Volume Metrics in Predicting Adverse Outcomes
Mascherbauer K, Kronberger C, Dona C, Koschutnik M, Dannenberg V, Poledniczek M, et al.
J Clin Med
. 2025 Jan;
14(2.
PMID: 39860388
Extracellular volume (ECV) by cardiovascular magnetic resonance (CMR) imaging is associated with disease burden and clinical outcomes. Recent studies in patients with valvular heart disease (VHD) have suggested that the...
3.
Dannenberg V, Zschocke F, Halavina K, Mascherbauer K, Heitzinger G, Koschutnik M, et al.
Eur J Clin Invest
. 2024 Dec;
55(3):e14367.
PMID: 39623565
Background: Severe tricuspid regurgitation (TR) is associated with high morbidity and mortality. Isolated TR, defined as TR without overt heart disease, is typical and offers limited cardiac treatment options other...
4.
Demirel C, Hamzaraj K, Seeber A, Hemetsberger R, Koschatko S, Jantsch C, et al.
Heart Lung
. 2024 Nov;
70:8-13.
PMID: 39541607
Background: Preprocedural evaluation, including frailty estimation, is crucial in managing patients undergoing Transcatheter Aortic Valve Replacement (TAVR). This involves mandatory computed tomography (CT) scans for assessing body composition parameters. The...
5.
Halavina K, Koschutnik M, Dona C, Autherith M, Petric F, Rockel A, et al.
JACC Cardiovasc Interv
. 2024 Sep;
17(17):2054-2066.
PMID: 39260962
Background: Fluid overload (FO) subjects patients with severe aortic stenosis (AS) to increased risk for heart failure and death after valve replacement and can be objectively quantified using bioimpedance spectroscopy...
6.
Dreyfus J, Juarez-Casso F, Sala A, Carnero-Alcazar M, Eixeres-Esteve A, Bohbot Y, et al.
Eur Heart J
. 2024 Aug;
45(42):4512-4522.
PMID: 39212387
Background And Aims: Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient...
7.
Heitzinger G, Spinka G, Prausmuller S, Pavo N, Dannenberg V, Dona C, et al.
JACC Adv
. 2024 Jun;
1(3):100063.
PMID: 38938405
Background: Secondary mitral regurgitation (sMR) in the setting of heart failure (HF) has considerable impact on quality of life, HF rehospitalizations, and mortality. Identification of high-risk cohorts is essential to...
8.
Wurm R, Prausmuller S, Ponleitner M, Spinka G, Weidenhammer A, Arfsten H, et al.
JACC Heart Fail
. 2024 Jun;
12(6):1073-1085.
PMID: 38839151
Background: Cognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes. Novel blood-based biomarkers have emerged as potential diagnostic tools for neurodegeneration....
9.
Arfsten H, Heitzinger G, Prausmuller S, Weidenhammer A, Goliasch G, Bartko P, et al.
ESC Heart Fail
. 2024 Mar;
11(3):1748-1757.
PMID: 38459668
Aims: Regulation of the renin-angiotensin system (RAS) in heart failure (HF) with reduced ejection fraction (HFrEF) still raises questions, as a large proportion of patients show normal renin levels despite...
10.
Demirel C, Winter M, Nitsche C, Koschatko S, Jantsch C, Mascherbauer K, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jan;
25(5):718-726.
PMID: 38236149
Aims: Transcatheter aortic valve replacement (TAVR) revolutionized the therapy of severe aortic stenosis (AS) with rising numbers. Mixed aortic valve disease (MAVD) treated by TAVR is gaining more interest, as...